 Connection
Everett Magann to Hydroxyprogesterones
This is a "connection" page, showing publications Everett Magann has written about Hydroxyprogesterones.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.515 |
|
|
|
-
Ghahremani T, Phillips A, Magann EF, McCoy H, Whittington J, Ounpraseuth S, Eswaran H. 17 Alpha-hydroxyprogesterone caproate use in a rural state. J Matern Fetal Neonatal Med. 2022 Dec; 35(25):6437-6439.
Score: 0.192
-
Schuit E, Stock S, Rode L, Rouse DJ, Lim AC, Norman JE, Nassar AH, Serra V, Combs CA, Vayssiere C, Aboulghar MM, Wood S, ?eting?z E, Briery CM, Fonseca EB, Worda K, Tabor A, Thom EA, Caritis SN, Awwad J, Usta IM, Perales A, Meseguer J, Maurel K, Garite T, Aboulghar MA, Amin YM, Ross S, Cam C, Karateke A, Morrison JC, Magann EF, Nicolaides KH, Zuithoff NP, Groenwold RH, Moons KG, Kwee A, Mol BW. Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis. BJOG. 2015 Jan; 122(1):27-37.
Score: 0.121
-
Briery CM, Klauser CK, Martin RW, Magann EF, Chauhan SP, Morrison JC. The use of 17-hydroxy progesterone in women with arrested preterm labor: a randomized clinical trial. J Matern Fetal Neonatal Med. 2014 Dec; 27(18):1892-6.
Score: 0.117
-
Briery CM, Veillon EW, Klauser CK, Martin RW, Chauhan SP, Magann EF, Morrison JC. Progesterone does not prevent preterm births in women with twins. South Med J. 2009 Sep; 102(9):900-4.
Score: 0.086
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|